Scientists at Penn State have turned a long-standing assumption on its head by coaxing superconductivity out of iron ...

Merck has initiated MALBEC, its phase 2b/3 clinical trial evaluating MK-8748 (also known as Tiespectus, EYE201) for the ...

Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced that ...

Study will highlight novel iNKT cell-based combinations in checkpoint-refractory diseaseData expected to inform immune modulation, treatment ...

A heat-resistant titanium dioxide scaffold makes it possible to nanoimprint reconfigurable phase-change metasurfaces over ...

SYDNEY, April 01, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that the first participant has been treated in the open-label extension (OLE) phase of the XanaMIA trial ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...

A single MXene-based optical gate switches between seven Boolean logic functions via voltage, enabling trainable photonic ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat population; Phase 1b data demonstrate ...

Minor adjustments to switching frequency, thermal management, bias power, and inductor selection improves 48V buck converter ...

Abstract: In this work, an amplitude-induced phase control method is proposed to achieve phase modulation by performing vector synthesis of two components with a tunable amplitude ratio. With a fixed ...